Related Articles

• 2009 California Biomedical Industry Report Released
• ACTION ALERT: Tax Code Changes
• Biotech is Seen as Safe Haven
• Budget Deal Emerges But Passage Still Uncertain
• California Healthcare Institute to Host Conversation on Healthcare Reform with Former Secretary of State and Leading Economists
• CHI Applauds Members of the California Delegation Pushing for Research Incentive
• CHI Gathers Lawmakers and Biomedical Industry to Create Solutions to Keep Innovation in California
• CHI Launches Podcast to Help Entrepreneurs Find New Sources of Funding
• CHI Member Acadia Scores Partnership for Parkinson Drug
• CHI Organizes Letter Opposing Troublesome Medical Device Tax
• CHI Signs Letter to Governor Concerning R&D Tax Credit Changes
• CHI Submits Letter to Congress Urging Increased Funding for NIH
• CHI Supports Eshoo Amendment
• Colorado Loves California?
• Congress Works to Resolve Differences in Healthcare Reform Bills
• Deals Abound, Giving Investors New Hope
• Delegation Members Voice Concern With Medical Device Tax
• Early Bird Registration Now Available for The Healthcare Policy Forum-Innovation at a Crossroads
• Editorial: No on Prop. 24
• Gen-Probe CEO Carl Hull Speaks out on Medical Device Tax
• Gilead Sciences Ranked Number One on BusinessWeek 50
• House Committee Proposes $37 Billion Tax on Drug Advertising
• House Defeats Amendment to Strip Small Company SOX Exemptions
• Impact of Proposed Medical Technology Manufacturing Fee on California
• Legislators Agree to State Budget
• Medical Device and Diagnostics Tax May Hinder Innovation
• Medtronic Chairman and CEO Applauds Revised Medical Device Industry Tax Proposal
• New CHI Blog Entry: CHI Attends The Commission Meeting on The 21st Century Economy
• New Deals Energize Biotech Sector
• Pfizer Abandons Plans to Build Biotech Research Center in San Francisco
• Report: California is Losing Manufacturing Jobs
• Reversing California's Downward Trend: OpEd by Carl Hull, Gen-Probe Incorporated
• Roche Buys the Rest of Genentech for $48.6 Billion
• Roche Buys the Rest of Genentech for $48.6 Billion
• San Jose Focusing on Becoming Next Major Life Sciences Hub
• Schwarzenegger Signs Calif. Budget 85 Days Late
• Second Tier Funding Options Considered By Biotechs as IPO Well Stays Dry
• Senators Boxer and Feinstein Voice Concerns on Proposed Medical Device Tax
• Small Biotechs Struggling to Find Funding
• Survey Finds Venture Capital Valuations Up for Life Sciences Companies
• Tax Breaks Encourage Affymetrix to Relocate Manufacturing to Singapore
• Tax Proposal Will Make California the Most Expensive State
• The Honorable Willie L.Brown Jr. Will Give a Keynote Address at the California Life Sciences Day
• The Jobs Tax Officially Qualifies for the November Ballot
• Therapeutic Discovery Project Tax Credit Application Now Available
• What is in Store for the Biotech Industry in 2009?